Statement Of Financial Position [Abstract]
| Concept |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2020-12-31 |
As at 2020-12-31 |
As at 2020-12-31 |
As at 2020-12-31 |
As at 2020-12-31 |
As at 2020-12-31 |
As at 2019-12-31 |
As at 2019-12-31 |
As at 2019-12-31 |
As at 2019-12-31 |
As at 2019-12-31 |
As at 2019-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Statement of financial position [abstract] | ||||||||||||||||||
| Assets [abstract] | ||||||||||||||||||
| Non-current assets [abstract] | ||||||||||||||||||
| Property, plant and equipment |
264,449,000
USD
|
— | — | — | — | — |
257,080,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Right-of-use assets |
2,604,000
USD
|
— | — | — | — | — |
3,337,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Trade and other non-current receivables |
26,000
USD
|
— | — | — | — | — |
30,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Non-current assets |
267,833,000
USD
|
— | — | — | — | — |
261,285,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Current assets [abstract] | ||||||||||||||||||
| Current inventories |
6,590,000
USD
|
— | — | — | — | — |
2,713,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Trade and other current receivables |
1,449,000
USD
|
— | — | — | — | — |
1,869,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Current biological assets |
16,795,000
USD
|
— | — | — | — | — |
24,610,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Cash and cash equivalents |
17,480,000
USD
|
— | — | — | — | — |
28,909,000
USD
|
— | — | — | — | — | — |
24,471,000
USD
|
— | — | — | — |
| Current assets |
43,907,000
USD
|
— | — | — | — | — |
59,674,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Assets |
311,740,000
USD
|
— | — | — | — | — |
320,959,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Equity and liabilities [abstract] | ||||||||||||||||||
| Equity [abstract] | ||||||||||||||||||
| Issued capital |
1,051,000
USD
|
— | — | — | — | — |
917,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Retained earnings |
215,403,000
USD
|
— | — | — | — | — |
82,625,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Share premium |
454,256,000
USD
|
— | — | — | — | — |
335,337,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Equity |
239,556,000
USD
|
215,403,000
USD
|
454,256,000
USD
|
3,741,000
USD
|
4,089,000
USD
|
1,051,000
USD
|
255,459,000
USD
|
917,000
USD
|
82,625,000
USD
|
185,000
USD
|
335,337,000
USD
|
2,015,000
USD
|
27,432,000
USD
|
208,679,000
USD
|
2,586,000
USD
|
236,819,000
USD
|
1,060,000
USD
|
818,000
USD
|
| Liabilities [abstract] | ||||||||||||||||||
| Non-current liabilities [abstract] | ||||||||||||||||||
| Non-current liabilities |
52,842,000
USD
|
— | — | — | — | — |
54,247,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Current liabilities [abstract] | ||||||||||||||||||
| Trade and other current payables |
19,018,000
USD
|
— | — | — | — | — |
10,771,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Current liabilities |
19,342,000
USD
|
— | — | — | — | — |
11,253,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Liabilities |
72,184,000
USD
|
— | — | — | — | — |
65,500,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Equity and liabilities |
311,740,000
USD
|
— | — | — | — | — |
320,959,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |